BlackRock’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15M | Buy |
|
|||||
|
2025
Q2 | $14.8M | Buy |
|
|||||
|
2025
Q1 | $8.46M | Sell |
|
|||||
|
2024
Q4 | $13.1M | Buy |
|
|||||
|
2024
Q3 | $53.9M | Buy |
|
|||||
|
2024
Q2 | $34.8M | Buy |
|
|||||
|
2024
Q1 | $9.39M | Buy |
|
|||||
|
2023
Q4 | $1.82M | Hold |
|
|||||
|
2023
Q3 | $1.24M | Sell |
|
|||||
|
2023
Q2 | $3.57M | Buy |
|
|||||
|
2023
Q1 | $3.19M | Buy |
|
|||||
|
2022
Q4 | $607K | Buy |
|
|||||
|
2022
Q3 | $562K | Sell |
|
|||||
|
2022
Q2 | $756K | Buy |
|
|||||
|
2022
Q1 | $885K | Buy |
|
|||||
|
2021
Q4 | $945K | Sell |
|
|||||
|
2021
Q3 | $1.55M | Sell |
|
|||||
|
2021
Q2 | $1.97M | Sell |
|
|||||
|
2021
Q1 | $3.31M | Buy |
|
|||||
|
2020
Q4 | $520K | Buy |
|
|||||
|
2020
Q3 | $673K | Buy |
|
|||||
|
2020
Q2 | $641K | Sell |
|
|||||
|
2020
Q1 | $613K | Buy |
|
|||||
|
2019
Q4 | $664K | Buy |
|
|||||
|
2019
Q3 | $284K | Buy |
|
|||||
|
2019
Q2 | $361K | Buy |
|
|||||
|
2019
Q1 | $321K | Buy |
|
|||||
|
2018
Q4 | $262K | Buy |
|
|||||
|
2018
Q3 | $452K | Buy |
|
|||||
|
2018
Q2 | $391K | Buy |
|
|||||
|
2018
Q1 | $364K | Sell |
|
|||||
|
2017
Q4 | $350K | Buy |
|
|||||
|
2017
Q3 | $453K | Buy |
|
|||||
|
2017
Q2 | $547K | Sell |
|
|||||
|
2017
Q1 | $563K | Buy |
|